InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Vance Terry. Director active across 1 company, notably Enanta Pharmaceuticals INC. Cumulatively, 2 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €129k. Activity tracked since 16 March 2023. The latest transaction was disclosed on 13 December 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations